Aegera Therapeutics Inc.: Application Deployment Made Easy
Aegera Therapeutics Inc.: Application Deployment Made Easy
1 Pages: CASE STUDY www.specopssoft.com Aegera Therapeutics, Inc., a clinical stage biotechnology company, develops drugs to control apoptosis. It provides AEG35156 for the treatment of solid tumors and leukemia; small molecule IAP inhibitors for the treatment of multiple cancers, in- ? ammatory, and autoimmune diseases; and oral small molecules for the treatment of neuropathic pain and neuropathies induced by diabetes. The IT staff at Aegera Therape
